ASEP Medical Holdings, Inc. engages in the acquisition of assets, technology, and businesses in the area of life sciences and medical diagnostics. The company is headquartered in Victoria, British Columbia. The company went IPO on 2021-11-22. The firm consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. The firm offers a rare combination of both a novel diagnostic and a therapeutic approach. The Company’s lead product was developed through its subsidiary, Sepset Biosciences Inc., which utilizes proprietary diagnostic tools to enable the early and timely identification of sepsis. ABT Innovations Inc. provides broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections. SafeCoat Medical Inc. provides an antimicrobial peptide, anti-fouling medical device coating technology.
Asep Medical Holdings Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Precision BioSciences Inc 주요 수익원은 In Vivo Therapies이며, 최신 수익 발표에서 수익은 34,264,000입니다. 지역별로는 United States이 Precision BioSciences Inc의 주요 시장이며, 수익은 34,264,000입니다.
Asep Medical Holdings Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Precision BioSciences Inc의 순손실은 $0입니다.